DOI QR코드

DOI QR Code

New Oncologic Imaging Section in the Korean Journal of Radiology

  • Seong Ho Park (Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2023.11.21
  • Accepted : 2023.11.21
  • Published : 2024.01.01

Abstract

Keywords

References

  1. US FDA. Tissue agnostic drug development in oncology: draft guidance for industry [accessed on November 20, 2023]. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/tissue-agnostic-drug-development-oncology 
  2. Kim N, Lee ES, Won SE, Yang M, Lee AJ, Shin Y, et al. Evolution of radiological treatment response assessments for cancer immunotherapy: from iRECIST to radiomics and artificial intelligence. Korean J Radiol 2022;23:1089-1101  https://doi.org/10.3348/kjr.2022.0225
  3. Xiao L, Yu S, Xu W, Sun Y, Xin J. (99m)Tc-3PRGD(2) SPECT/CT imaging for diagnosing lymph node metastasis of primary malignant lung tumors. Korean J Radiol 2023;24:1142-1150  https://doi.org/10.3348/kjr.2023.0411
  4. Woo C, Jo KH, Sohn B, Park K, Cho H, Kang WJ, et al. Development and testing of a machine learning model using (18)F-fluorodeoxyglucose PET/CT-derived metabolic parameters to classify human papillomavirus status in oropharyngeal squamous carcinoma. Korean J Radiol 2023;24:51-61  https://doi.org/10.3348/kjr.2022.0397
  5. Wang Y, Gao F. Research progress of CXCR4-targeting radioligands for oncologic imaging. Korean J Radiol 2023;24:871-889  https://doi.org/10.3348/kjr.2023.0091
  6. Cheng L, Yang T, Zhang J, Gao F, Yang L, Tao W. The application of radiolabeled targeted molecular probes for the diagnosis and treatment of prostate cancer. Korean J Radiol 2023;24:574-589  https://doi.org/10.3348/kjr.2022.1002
  7. Yang X, Lu X, Liu J, Kan Y, Wang W, Zhang S, et al. Development and validation of (18)F-FDG PET/CT-based multivariable clinical prediction models for the identification of malignancy-associated hemophagocytic lymphohistiocytosis. Korean J Radiol 2022;23:466-478  https://doi.org/10.3348/kjr.2021.0733
  8. Li S, Li Y, Zhao M, Wang P, Xin J. Combination of (18) F-fluorodeoxyglucose PET/CT radiomics and clinical features for predicting epidermal growth factor receptor mutations in lung adenocarcinoma. Korean J Radiol 2022;23:921-930  https://doi.org/10.3348/kjr.2022.0295
  9. Futterer JJ, Nagarajah J. Research highlight: (68)Ga-PSMA-11 PET imaging for pelvic nodal metastasis in prostate cancer. Korean J Radiol 2022;23:293-294  https://doi.org/10.3348/kjr.2021.0938
  10. Bu L, Tu N, Wang K, Zhou Y, Xie X, Han X, et al. Relationship between (18)F-FDG PET/CT semi-quantitative parameters and international association for the study of lung cancer, american thoracic society/european respiratory society classification in lung adenocarcinomas. Korean J Radiol 2022;23:112-123 https://doi.org/10.3348/kjr.2021.0455